Core Viewpoint - Bollinger Innovations, Inc. will implement a 1-for-250 reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00, effective September 22, 2025 [2][3][4] Group 1: Reverse Stock Split Details - The reverse stock split will convert 250 shares of common stock into one share, resulting in approximately 505 thousand shares post-split, down from approximately 126.2 million shares [5] - The reverse stock split will not change the par value of the common stock or the authorized number of shares [4] - No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share [5] Group 2: Compliance and Approval - The reverse stock split was approved by the stockholders at a special meeting on September 11, 2025, with the board of directors selecting the 1-for-250 ratio [3] - The primary goal of the reverse stock split is to ensure compliance with Nasdaq's listing standards, although there is no guarantee that the company will maintain compliance [2] Group 3: Company Overview - Bollinger Innovations is an electric vehicle manufacturer based in Southern California, focusing on commercial electric vehicles with a manufacturing facility in Tunica, Mississippi [7] - The company offers the ONE Class 1 EV cargo van and the THREE Class 3 EV cab chassis truck, supported by a dealer network across key U.S. markets [7]

As filed with the Securities and Exchange Commission on September 17, 2025 Registration No. 333-286850 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Safe & Green Holdings Corp. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 5030 95-4463937 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifi ...

Core Points - ECD Automotive Design, Inc. will implement a 1-for-40 reverse stock split effective September 18, 2025, to increase its stock price above the $1.00 minimum bid requirement for Nasdaq listing [1][2] - The reverse stock split will reduce the number of outstanding shares from approximately 59,091,136 to about 1,477,278 shares, without changing the number of authorized shares or par value [3] - Shareholders holding shares electronically will not need to take action, while those with certificated shares will receive instructions from the transfer agent [4] Company Overview - ECD is the world's largest Land Rover and Jaguar restoration company, known for custom luxury builds including bespoke Defenders, Range Rovers, and Jaguar E-Types [1][6] - Founded in 2013, ECD combines classic vehicle aesthetics with modern performance, employing 102 staff, including 67 craftsmen with numerous certifications [6] - The company operates from a 100,000-square-foot facility in Kissimmee, Florida, and has a logistics center in the U.K. for sourcing restoration vehicles [6]

Core Points - Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on therapies for neurodegenerative diseases [1] - A reverse stock split will occur on September 18, 2025, consolidating shares at a ratio of 1-for-10, approved by stockholders [1][2] - The reverse stock split aims to enhance the stock's marketability and potentially attract more investors [1][4] Stock Performance - Currently, ATHA's stock is priced at $0.38, with a slight increase of 0.29% or $0.0011 [3] - The stock has shown volatility, with a low of $0.35 and a high of $0.40 on the current trading day [3] - Over the past year, ATHA's stock has fluctuated between a high of $0.83 and a low of $0.22 [3] Market Capitalization and Trading Volume - Athira Pharma's market capitalization is approximately $15.1 million [4] - The trading volume on the NASDAQ exchange is 586,605 shares [4] - The reverse stock split may reduce the number of shares outstanding, potentially increasing the stock price [4]

Core Viewpoint - Biodesix, Inc. announced a one-for-twenty reverse stock split effective September 15, 2025, aimed at reducing the number of outstanding shares and potentially improving the stock's market perception [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders on May 20, 2025, with the final ratio determined by the board of directors [2]. - The number of shares will decrease from approximately 156 million to about 8 million, with adjustments for fractional shares [2]. - The reverse stock split will not change stockholders' percentage ownership interests, except for fractional shares, which will be compensated in cash [3]. Group 2: Impact on Equity Incentive Plans - The number of shares available under the Company's equity incentive plans and the exercise prices of outstanding options and warrants will be proportionately adjusted [4]. Group 3: Administrative Process - Computershare Trust Company, N.A. will act as the transfer agent, managing the transition to post-split shares without requiring action from registered stockholders [5]. - Stockholders with certificated shares will receive instructions from Computershare on how to surrender their pre-split shares [5]. Group 4: Company Overview - Biodesix is a leader in personalized diagnostics, focusing on improving clinical care and outcomes for patients, particularly in lung disease [7].

Core Viewpoint - Lucid Group executed a 1-for-10 reverse stock split to increase its share price and reduce outstanding shares, aiming to attract a broader range of investors despite a challenging year for the EV industry [1][2][5]. Company Summary - The reverse stock split reduced Lucid's outstanding shares from over 3.07 billion to 307.3 million, increasing the stock price from just over $2 to about $17 [3]. - Management believes the reverse split will make the stock more appealing to investors, especially compared to other EV stocks like Tesla and Rivian, which trade at higher prices [5]. - Lucid's revenue for the second quarter was $259 million, down from $280 million the previous year, and the company lowered its production guidance from 20,000 vehicles to a range of 18,000 to 20,000 [6]. Industry Summary - The EV industry is facing difficulties, particularly after the elimination of the $7,500 federal EV tax credit and the halt in the expansion of EV charging stations [6][10]. - Lucid has partnered with Uber, which will invest $300 million in the company, as part of a plan to deploy 20,000 robotaxis over the next six years [8]. - Despite a 32% revenue growth in the first half of 2025, Lucid's market cap exceeds $57 billion, indicating a high valuation relative to its sales [9].

Core Viewpoint - Lucid's stock is experiencing a significant decline following a reverse stock split, raising concerns about the company's stability and future performance [1][2][4]. Group 1: Stock Performance - Lucid shares fell 7.5% on Thursday, marking a three-day decline after the reverse stock split [1]. - The stock has dropped nearly 20% since the opening of trading on Tuesday, despite the overall market gaining [2][4]. Group 2: Reverse Stock Split - The reverse stock split reduced the number of shares held by shareholders to 10% of the previous amount, with each share now valued at ten times more [2]. - Reverse splits are generally perceived negatively by the market, often indicating financial trouble for the company [2]. - The split was intended to make Lucid's stock more appealing to institutional investors, who typically have minimum share value requirements [4]. Group 3: Company Outlook - There are doubts about Lucid's ability to execute a necessary turnaround, leading to skepticism about the stock's future performance [5].

Core Viewpoint - HealthLynked Corp. is committed to long-term growth and enhancing shareholder value through strategic initiatives, including a reverse stock split to strengthen its capital structure and market positioning [1][2][3]. Share Structure and Market Positioning - The company has completed a reverse stock split, reducing the number of outstanding shares, which increases the per-share price without diluting ownership [2][3]. - This non-dilutive step aims to improve visibility and attract institutional investors, particularly those requiring a minimum share price for participation [3]. Growth Initiatives - HealthLynked has launched its AI healthcare guide, ARi, and is building commercial traction through its telemedicine platform and digital services, which are gaining momentum [4]. - The company is in discussions with major insurance carriers to integrate its technology into care management workflows, potentially driving substantial recurring revenue [5]. Intellectual Property and Innovation - HealthLynked is expanding its intellectual property portfolio, focusing on existing patents in healthcare and AI to support future innovation and maintain market leadership [5]. Future Outlook - The reverse stock split is part of a broader strategy to enhance shareholder value, attract institutional support, and scale operations, with a focus on executing a bold vision for the company's technology [5].

Company Announcement - TIAN RUIXIANG Holdings Ltd. will implement a reverse stock split at a ratio of five (5) to one (1), effective September 5, 2025, with shares trading under the same ticker symbol TIRX on the Nasdaq Capital Market [1] - The par value of the Company's Class A and Class B ordinary shares will increase from US$0.025 to US$0.125 per share as part of the reverse stock split [2] - No fractional shares will be issued; any fractional entitlements will be rounded up to the nearest whole share [2] Company Overview - TIAN RUIXIANG Holdings Ltd. is an insurance broker based in Beijing, China, operating through a variable interest entity [3] - The Company distributes a variety of insurance products, categorized into property and casualty insurance, and other types of insurance such as health and life insurance [3]

Core Points - Oxford Lane Capital Corp. announced a 1-for-5 reverse stock split effective September 5, 2025, with trading on a split-adjusted basis starting September 8, 2025 [1] - The reverse stock split will consolidate every five shares of common stock into one share, maintaining the par value at $0.01 per share [1] - The new CUSIP number for the common stock post-split will be 691543 847 [1] Monthly Distributions - Following the reverse stock split, monthly distributions will be adjusted as follows: - September 30, 2025: $0.45 per share [2] - October 31, 2025: $0.40 per share [2] - November 30, 2025: $0.40 per share [2] - December 31, 2025: $0.40 per share [2] - No fractional shares will be issued; shareholders entitled to fractional shares will receive cash payments instead [2] Shareholder Actions - Shareholders holding common stock in book-entry form or through a nominee do not need to take any action regarding the reverse stock split [3] - Shareholders of record will receive information from the transfer agent about their post-split ownership [3] - Stockholders with certificate shares will receive instructions on how to exchange their certificates for a statement of holding [3] Company Overview - Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company focused on investing in debt and equity tranches of collateralized loan obligation (CLO) vehicles [4]